ftInvstr
METROPOLIS · Healthcare ₹590.5 -0.13% Mkt Cap ₹12220 Cr overvalued

METROPOLIS

Healthcare Diagnostics & Research
₹590.5
-0.13% today · 30d +5.82%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for METROPOLIS. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹450 Cr
+16.62% YoY
NET PROFIT
₹57 Cr
+25.72% YoY
OPM
25.54%
+0.83pp YoY
EPS
₹2.73
PE 59.14
Intrinsic value · DCF ₹270.72 · Margin of safety -54.2% (overvalued) · FCF yield 2.51%
◇ Sector Position
PEERPEROCE %
METROPOLIS59.1418.0
SAILIFE93.1518.42
LALPATHLAB62.2931.74
SYNGENE72.0416.59
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
68
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation STRETCHED 20
Growth STRONG 80
Profitability HIGH 85
Technicals NEUTRAL 65
Risk LOW 80
Key Stats
TTM PE
59.14
P/B
7.92
52W HIGH
₹609.05
OFF HIGH
-3.05%
DIV YIELD
0.34%
MKT CAP
₹12220 Cr
◉ Active Signals
MACDBullish3.0854
RSI(14)Bullish60.31
Near 52W HighBullish-3.05
Street Consensus
19 analysts
₹658.16
mean target
Low ₹500.0Now ₹590.5High ₹760.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold METROPOLIS and at what entry.

Sign up freeSign in